src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-8050569412065003" crossorigin="anonymous">[/script]

Hims & Hers shares fall after FDA says semaglutide no longer in shortage newsthirst.

Shares of Hims & Hers Health tumbled more than 23% on Friday after the U.S. Food and Drug Administration announced that the shortage of semaglutide injection products has been resolved. Semaglutide is the active ingredient in Novo Nordisk’s blockbuster weight loss drug Wegovy and diabetes treatment Ozempic. Those medications are part of a class of drugs called…

Read More

MrBeast, Logan Paul and KSI’s Lunchly meal brand face FDA complaints over mold newsthirst.

Oct 27, 2024 12:24 AM IST The issues surrounding Lunchly recently became viral after YouTuber Rosanna Pansino posted a video where she reviewed the product. Lunchly, the Lunchables-style meal brand launched by MrBeast, Logan Paul, and KSI, is facing FDA complaints over mold, reported TMZ. The federal agency has received multiple complaints against the YouTubers’…

Read More